NeuroPace (NPCE) Amortizatization of Intangibles (2022 - 2026)
NeuroPace (NPCE) posted Amortizatization of Intangibles of $464000.0 for Q2 2026, up 2.43% on a QoQ basis from $453000.0 in Q1 2026, and up 9.95% year-over-year from $422000.0 in Q2 2025.
Powered by 
Analysis
NeuroPace (NPCE) Amortizatization of Intangibles (2022 - 2026) Analysis & Trends
NeuroPace has reported Amortizatization of Intangibles for 5 years, with the latest figure at $464000.0 in Q2 2026.
- On a quarterly basis, Amortizatization of Intangibles rose 9.95% year-over-year to $464000.0 in Q2 2026; TTM through Jun 2026 was $1.8 million, a 9.74% increase from a year earlier, with the FY2025 full-year figure at $1.7 million, up 9.48% from the prior year.
- Amortizatization of Intangibles was $464000.0 for Q2 2026 at NeuroPace, up from $453000.0 in the prior quarter.
- The five-year high for Amortizatization of Intangibles was $698000.0 in Q4 2022, with the low at $347000.0 in Q1 2023.
- Average Amortizatization of Intangibles over 5 years is $463444.4, with a median of $417500.0 recorded in 2025.
- The sharpest annual moves came in 2023 and 2026: Amortizatization of Intangibles sank 48.36% in 2023, then grew 9.95% in 2026.
- Over 5 years, Amortizatization of Intangibles stood at $698000.0 in 2022, then sank by 47.13% to $369000.0 in 2023, then rose by 9.21% to $403000.0 in 2024, then gained by 9.68% to $442000.0 in 2025, then rose by 4.98% to $464000.0 in 2026.
- The last three Amortizatization of Intangibles figures came in at $464000.0 (Q2 2026), $453000.0 (Q1 2026), and $442000.0 (Q4 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Amortizatization of Intangibles (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 183.04 Bn | 177.44 Bn | 7.27 Bn | - |
| 2 | Intuitive Surgical | 125.02 Bn | 119.81 Bn | 1.96 Bn | 38.80 Mn |
| 3 | Medtronic | 117.84 Bn | 109.02 Bn | 6.34 Bn | - |
| 4 | Stryker | 105.50 Bn | 102.02 Bn | 4.50 Bn | - |
| 5 | Boston Scientific | 66.27 Bn | 65.73 Bn | 3.85 Bn | - |
| 6 | Edwards Lifesciences | 49.60 Bn | 45.35 Bn | 1.35 Bn | 6.60 Mn |
| 7 | Alcon | 33.70 Bn | 32.24 Bn | 1.68 Bn | - |
| 8 | Dexcom | 32.06 Bn | 30.11 Bn | 830.00 Mn | - |
| 9 | Steris | 21.02 Bn | 20.54 Bn | 684.20 Mn | - |
| 10 | NeuroPace | 493.15 Mn | 441.45 Mn | 18.91 Mn | 464,000.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 464,000.00 |
| Mar 31, 2026 | 453,000.00 |
| Dec 31, 2025 | 442,000.00 |
| Sep 30, 2025 | 433,000.00 |
| Jun 30, 2025 | 422,000.00 |
| Mar 31, 2025 | 413,000.00 |
| Dec 31, 2024 | 403,000.00 |
| Sep 30, 2024 | 395,000.00 |
| Jun 30, 2024 | 386,000.00 |
| Mar 31, 2024 | 378,000.00 |
| Dec 31, 2023 | 369,000.00 |
| Sep 30, 2023 | 362,000.00 |
| Jun 30, 2023 | 355,000.00 |
| Mar 31, 2023 | 347,000.00 |
| Dec 31, 2022 | 698,000.00 |
| Sep 30, 2022 | 679,000.00 |
| Jun 30, 2022 | 671,000.00 |
| Mar 31, 2022 | 672,000.00 |